Literature DB >> 34985403

Evaluation of HPV Vaccine: Same Way, Same DayTM: A Pilot Study.

James M Bishop1, Francis J Real2, Skye L McDonald3, Melissa Klein2, Dominick DeBlasio2, Jessica A Kahn2, Gary L Kreps4, Brittany L Rosen2.   

Abstract

Missed clinical opportunities and the lack of strong and consistent vaccine recommendations are key reasons for low HPV vaccination rates. The purpose of this study was to conduct a pilot evaluation of a web-based training's impact on knowledge, attitudes, and self-efficacy related to providing evidence-based HPV vaccine recommendations. Participants completed three online interactive learning modules and the HPV Vaccine: Same Way, Same Day™ smartphone application (app). Participants completed a pre-training survey, immediate post-training survey, and two-month post-survey. Participants demonstrated a statistically significant increase in knowledge scores from T1 to T2 and T1 to T3. Mean attitudes for recommending HPV vaccination for female patients increased from T1 to T2 and T1 to T3. Mean attitudes for recommending HPV vaccination for male patients increased from T1 to T2 and T1 to T3. Mean self-efficacy scores increased from T1 to T2 and T1 to T3. The HPV Vaccine: Same Way, Same Day™ app is a promising strategy for improving HPV vaccine recommendations among physicians. Future research should explore long-term effects and enroll attending and community physicians to examine its efficacy in other physician populations.

Entities:  

Mesh:

Substances:

Year:  2022        PMID: 34985403     DOI: 10.1080/10810730.2021.2021459

Source DB:  PubMed          Journal:  J Health Commun        ISSN: 1081-0730


  1 in total

1.  A clinician's dilemma: what should be communicated to women with oncogenic genital HPV and their partners regarding the risk of oral viral transmission?

Authors:  Ermelinda Monti; Giussy Barbara; Giada Libutti; Veronica Boero; Fabio Parazzini; Andrea Ciavattini; Giorgio Bogani; Lorenzo Pignataro; Beatrice Magni; Camilla Erminia Maria Merli; Paolo Vercellini
Journal:  BMC Womens Health       Date:  2022-09-17       Impact factor: 2.742

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.